Io Biotech, Inc. (IOBT) — 8-K Filings

8-K Filings (23)

• IO Biotech Files 8-K: Bankruptcy, Financial Obligations, Officer Changes — Mar 31, 2026 Risk: high
  IO Biotech, Inc. filed an 8-K on March 31, 2026, reporting on several key events. These include potential bankruptcy or receivership proceedings, triggering eve
• IO Biotech Faces Delisting Concerns — Dec 19, 2025 Risk: high
  IO Biotech, Inc. filed an 8-K on December 19, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company, inc
• IO Biotech Announces Board Changes — Nov 21, 2025 Risk: low
  IO Biotech, Inc. announced on November 17, 2025, a change in its board of directors. Specifically, the company reported the departure of a director and the elec
• IO Biotech Files 8-K with Corporate Updates — Nov 18, 2025 Risk: low
  IO Biotech, Inc. filed an 8-K on November 18, 2025, reporting on events that require disclosure under Regulation FD and including financial statements and exhib
• IO Biotech 8-K: Exit/Disposal Costs Reported — Sep 29, 2025 Risk: medium
  IO Biotech, Inc. filed an 8-K on September 29, 2025, reporting on events as of September 25, 2025. The filing indicates costs associated with exit or disposal a
• IO Biotech Files 8-K on Operations and Financials — Aug 11, 2025 Risk: low
  IO Biotech, Inc. filed an 8-K on August 11, 2025, reporting on its results of operations and financial condition, as well as other events. The filing also inclu
• IO Biotech Reports Unregistered Equity Sales — Jun 27, 2025 Risk: medium
  IO Biotech, Inc. filed an 8-K on June 27, 2025, reporting unregistered sales of equity securities and other events. The filing details events that occurred on J
• IO Biotech Announces Board and Executive Changes — Jun 20, 2025 Risk: medium
  IO Biotech, Inc. announced on June 19, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of cert
• IO Biotech Files 8-K on Security Holder Vote Matters — Jun 9, 2025 Risk: low
  IO Biotech, Inc. filed an 8-K on June 9, 2025, reporting on matters submitted to a vote of its security holders as of June 5, 2025. The filing details the compa
• IO Biotech Files 8-K: Corporate Updates — Jun 4, 2025 Risk: low
  IO Biotech, Inc. filed an 8-K on June 4, 2025, reporting other events and financial statements. The filing details the company's principal executive offices loc
• IO Biotech Files 8-K on Financials — May 14, 2025 Risk: low
  IO Biotech, Inc. filed an 8-K on May 14, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
• IO Biotech Reports Unregistered Equity Sales — Apr 30, 2025 Risk: medium
  IO Biotech, Inc. filed an 8-K on April 30, 2025, reporting unregistered sales of equity securities and other events. The filing details the company's principal
• IO Biotech Files 8-K on Financials and Operations — Mar 4, 2025 Risk: medium
  IO Biotech, Inc. filed an 8-K on March 4, 2025, reporting on its results of operations and financial condition. The filing also includes information related to
• IO Biotech Faces Delisting Concerns — Dec 27, 2024 Risk: high
  IO Biotech, Inc. filed an 8-K on December 27, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company, inc
• IO Biotech Files 8-K: Material Agreement & Financial Obligation — Dec 20, 2024 Risk: medium
  On December 19, 2024, IO Biotech, Inc. entered into a material definitive agreement and created a direct financial obligation. The company also reported unregis
• IO Biotech Files 8-K for Bylaw Amendments and Exhibits — Dec 16, 2024 Risk: low
  IO Biotech, Inc. filed an 8-K on December 16, 2024, reporting events that occurred on December 13, 2024. The filing primarily concerns amendments to its article
• IO Biotech Files 8-K on Financials and Exhibits — Nov 12, 2024 Risk: low
  IO Biotech, Inc. filed an 8-K on November 12, 2024, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits
• IO Biotech Files 8-K — Aug 30, 2024 Risk: low
  IO Biotech, Inc. filed an 8-K on August 30, 2024, reporting on other events and financial statements. The filing does not contain specific financial figures or
• IO Biotech Files 8-K on Operations and Financials — Aug 13, 2024 Risk: medium
  IO Biotech, Inc. filed an 8-K on August 13, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits.
• IO Biotech Files 8-K on Security Holder Vote Matters — Jun 11, 2024 Risk: medium
  IO Biotech, Inc. filed an 8-K on June 11, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 6, 2024. The company, i
• IO Biotech Announces Board and Executive Compensation Changes — Apr 26, 2024 Risk: medium
  On April 24, 2024, IO Biotech, Inc. announced changes in its board of directors and executive compensation arrangements. The filing details the departure of cer
• IO Biotech Files 8-K on Financials — Mar 5, 2024 Risk: low
  IO Biotech, Inc. filed an 8-K on March 5, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exh
• IO Biotech Files Routine 8-K, Confirms Nasdaq Listing — Jan 8, 2024
  IO Biotech, Inc. filed an 8-K on January 8, 2024, primarily to disclose general information and confirm its status as a registrant with common stock (IOBT) list

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX